IC
NVS icon

Iconiq Capital’s Novartis NVS Stock Holding History

Iconiq Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,135
Closed -$1.47M – 299
2025
Q2 		$1.47M Buy
12,135
+4,228
+53% +$477K 0.02% 76
2025
Q1 		$881K Buy
7,907
+1,833
+30% +$195K 0.02% 102
2024
Q4 		$591K Buy
6,074
+2,020
+50% +$215K 0.01% 129
2024
Q3 		$466K Buy
+4,054
New +$460K 0.01% 95

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Iconiq Capital's NVS Position: Q3 2025 in Review

Iconiq Capital sold out of Novartis (NVS) in Q3 2025, closing a stake of 12,135 shares — an estimated $1.47M sold.

Iconiq Capital first reported a position in NVS in Q3 2024 and held it in 4 quarters. The position peaked at $1.47M in Q2 2025. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Iconiq Capital reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Iconiq Capital sold 12,135 Novartis shares in Q3 2025, an estimated $1.47M.
  • Iconiq Capital first reported a position in Novartis in Q3 2024 and held it in 4 quarters.
  • Iconiq Capital's Novartis position peaked at $1.47M in Q2 2025.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Iconiq Capital's 13F filing for Q3 2025, filed 14 Nov 2025.